Purpose: Recent studies associate telomerase activity with prognostic facto
rs and survival. We compared quantitative telomerase activity in primary tu
mors with traditional prognostic factors and outcome in a group of invasive
but nonmetastatic breast cancers.
Patients and Methods: Telomerase activity was measured in 203 invasive brea
st cancers by the quantitative telomeric repeat amplification protocol meth
od. Telomerase expression was compared with 28S rRNA level, tumor content,
and clinical variables, including outcome. For clinical correlations, telom
erase activity was standardized by two methods: (1) a correction for cellul
arity using 285 rRNA levels, and (2) a correction for the histologically de
termined invasive proportion of the specimen.
Results: Telomerase activity was found in 82% of breast cancers with measur
able 28S rRNA levels. Telomerase activity was associated with the prolifera
tive index (P < .01) of the tumor but not with any other prognostic variabl
e. Neither uncorrected nor corrected telomerase activity was associated wit
h relapse-free or overall survival in this study.
Conclusion: Telomerase activity level was associated with the proliferative
index of invasive breast cancers, but its measurement in samples from this
group of nonmetastatic breast cancer patients did not predict survival. (C
) 1999 by American Society of Clinical Oncology.